Brainsway Ltd.

Brainsway Ltd. (BWAY) priced its initial public offering on Apr 17, 2019 at $11.00 per ADS, raising $27.5M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $119M. Cantor was lead-left underwriter, joined by Raymond James, Oppenheimer and Ladenburg Thalmann. Gross & Co. and Torys advised the company and Mintz advised the underwriters.

Brainsway Ltd. is a commercial-stage medical device company that develops and sells non-invasive Deep Transcranial Magnetic Stimulation products using its proprietary H-Coils. They are FDA-authorized to treat major depressive disorder and obsessive-compulsive disorder.

Status

IPO

Ticker

BWAY

Exchange

Nasdaq Global Market

Priced

Apr 17, 2019

IPO price

$11.00 per ADS

Raised

$27.5M

Market cap at IPO price

$119M

First filed

Apr 11, 2011

Underwriters

Cantor, Raymond James, Oppenheimer and Ladenburg Thalmann

Company counsel

Gross & Co. and Torys

Underwriters' counsel

Mintz

Sector

Healthcare

Country / state

Israel

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.